Clinical Trial Update: A Phase II Trail of Chidamide ,Rituximab and Methotrexate in Lymphoma Patients [Phase 2]

View source ↗

Summary

Phase II trial evaluating chidamide, rituximab, and methotrexate in Central Nervous System lymphoma is ongoing with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• METHOTREXATE (METHOTREXATE)
• Rituximab (rituximab)

Snippet

Sponsor: Fudan University | Conditions: Central Nervous System Lymphoma | Phase 2 | Status: UNKNOWN